Perfil
Krystof S.
Bankiewicz is the founder of Voyager Therapeutics, Inc. (founded in 2013) and Brain Neurotherapy Bio, Inc. (founded in 2018).
At Brain Neurotherapy Bio, Inc., he held the title of Chief Executive Officer from 2018 to 2024.
Currently, Dr. Bankiewicz is the Director-Interventional Neurology Center at The University of California, San Francisco.
Dr. Bankiewicz holds a doctorate degree from Uniwersytet Jagiellonski and Instytut Psychiatrii I Neurologii.
Cargos activos de Krystof S. Bankiewicz
| Empresas | Cargo | Inicio |
|---|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Krystof S. Bankiewicz.
| Empresas | Cargo | Fin |
|---|---|---|
Brain Neurotherapy Bio, Inc.
Brain Neurotherapy Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops transformative neurological gene therapies that restore and preserve health and well-being | Director Ejecutivo | 01/02/2024 |
| VOYAGER THERAPEUTICS, INC. | Fundador | - |
Formación de Krystof S. Bankiewicz.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Uniwersytet Jagiellonski
Uniwersytet Jagiellonski Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Instytut Psychiatrii I Neurologii
Instytut Psychiatrii I Neurologii Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Brain Neurotherapy Bio, Inc.
Brain Neurotherapy Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops transformative neurological gene therapies that restore and preserve health and well-being | Commercial Services |
- Bolsa de valores
- Insiders
- Krystof S. Bankiewicz
















